Alignment Healthcare (ALHC) Cash & Equivalents (2021 - 2026)

Alignment Healthcare's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $705.6 million for Q1 2026.

• Quarterly Cash & Equivalents rose 58.14% year-over-year to $705.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $705.6 million (up 58.14% YoY) and the FY2025 annual result came in at $575.8 million, up 33.03% from the prior year.
• Cash & Equivalents was $705.6 million for Q1 2026 at Alignment Healthcare, up from $575.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $705.6 million in Q1 2026 and bottomed at $202.9 million in Q4 2023.
• A 5-year average of $436.5 million and a median of $432.9 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents tumbled 50.46% — and 2024, when it soared 113.33%.
• Alignment Healthcare's Cash & Equivalents stood at $409.5 million in 2022, then tumbled by 50.46% to $202.9 million in 2023, then surged by 113.33% to $432.9 million in 2024, then jumped by 33.03% to $575.8 million in 2025, then grew by 22.54% to $705.6 million in 2026.
• Business Quant data shows ALHC's Cash & Equivalents at $705.6 million in Q1 2026, $575.8 million in Q4 2025, and $618.1 million in Q3 2025.